NIOWAVE, INC.

Overview

• HeadquartersMI¹
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Corporate structure

NIOWAVE, INC. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive OfficerTerry Grimm named Dec 15, 2021²
• DirectorJames Jensen named Dec 15, 2021²
• DirectorJerry Hollister named Dec 15, 2021²
• DirectorLee Grimm named Dec 15, 2021²
• DirectorMichael Seldowitz named Dec 15, 2021²
• DirectorMichael Zamiara named Dec 15, 2021²
• DirectorRoger Calantone named Dec 15, 2021²
• DirectorWilliam Demmer named Dec 15, 2021²

Filings

2 filings to the SEC since October 2021: 2 private raises. The latest 2:

1. Dec 15, 2021D EDGAR
2. Dec 15, 2021D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

NIOWAVE, INC. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Aptevo Therapeutics Inc.SCHEDULE 13G Jun 22, 2026³

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Mar 19, 2021Raised $1.7 million in a private offering of equity² Form D: $2 million offered in all Form D
2. Mar 6, 2020Raised $250,000 in a private offering of equity⁴ Form D: 1 investor so far Form D